Epidermal growth factor therapy and wound healing - Past, present and future perspectives

Surgeon

Volumn 6, Issue 3, 2008, Pages 172-177

  Hardwicke, J ^a,b,c   Schmaljohann, D ^b   Boyce, D ^c   Thomas, D ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c MORRISTON HOSPITAL   (United Kingdom)

Author keywords

Acute; Chronic; Epidermal growth factor; Healing; Polymer therapeutics; Wound

Indexed keywords

EID: 45249103749     PISSN: 1479666X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1479-666X(08)80114-X     Document Type: Review

References (38)

1. Greenhalgh D. The role of growth factors in wound healing. J Trauma 1996; 41: 159-67
2. Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eye-lid opening in the new-born animal. J Biol Chem 1962; 237: 1555-62
3. Prigent S, Lemoine N. The type I (EGFR-related) family of growth factor receptors and their ligands. Prog Growth Factor Res 1992; 4: 1-24
4. Carpenter G, King L, Cohen S. Epidermal growth factor stimulates phosphorylation in membrane preparations in vitro. Nature 1978; 276: 409-10
5. Carpenter G, Cohen S. Epidermal rowth factor. J Biol Chem 1990; 265: 7709-12
6. Brake A, Merryweather J, Coit D et al. Alpha-Factor-directed synthesis and secretion of mature foreign proteins in Saccharomyces cerevisiao. Proc Natl Acad Sci 1984; 81: 4642-46
7. Hong JP, Jung HD, Kim YW. Recombinant human epidermal growth factor to enhance healing for diabetic foot ulcers. Ann Plast Surg 2006; 56: 394-98
8. Tanaka A, Nagate T, Matsuda H. Acceleration of wound healing by gelatin film dressings with epidermal growth facton. J Vet Med Sci 2005; 67: 909-13
9. Franklin J, Lynch J. Effects of topical application of epidermal growth factor on wound healing. Plast Reconstr Surg 1979; 64: 766-70
10. Brown GL, Nanney LB, Griffen J et al. Enhancement of wound healing by topical treatment with epidermal growth factor, N Eng J Med 1989; 13: 321: 76-79
11. Falanga V, Eaglstein WH, Bucalo B et al. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers. J Dermatol Surg Oncol 1992; 18: 604-6
12. Smiell JM, Wieman TJ, Steed DL et al. Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen 1999; 7: 335-46
13. Frew S, Rezaie R, Sammut S et al. India's health biotech sector ata crossroads. Nat Biotechno 2007; 25: 403-17
14. Mola E, Acevedo B, Silva R et al. Development of Cuban Biotechnology. J Comm Biotechno 2003; 9: 147-52
15. Messing EM, Hanson P, Ulrich P, Erturk E. Epidermal growth factor-interactions with normal and malignant urothelium: in vivo and in situ studies. J Urol 1987; 138: 1329-35
16. Janmaat ML, Giaccone G. The epidermal growth factor receptor pathway and its inhibition as anti-cancer therapy. Drugs Today (Barc) 2003; 39C: 61-80
17. Barrandon Y, Green H. Cell migration is essential for sustaine growth of keratinocyte colonies: the roles of transforming growth factor-alpha and epidermal growth factor. Cell 1987; 50: 1131-37
18. Schultz G, Rotatori DS, Clark W. EGF and TGF-alpha in wound healing and repair. J Cell Biochem 1991; 45: 346 52
19. Savage C, Cohen S. Proliferation of corneal epithelium induced by epidermal growth factor. Eye Res 1973; 15: 361
20. Starkey R, Cohen S, Orth D. Epidermal growth fator: identification of a new hormone in human urine. Science 1975; 189: 800-2
21. Franklin J, Lynch J. EfFects of topical applications of epidermal growth factor on wound healing. Plast Roconstr Surg 1979; 64: 766-70
22. Brown G, Nanney L, Griffen J et al. Enhancement of wound healing by topical treatment with epidermal growth factor. N Eng J Med 1989; 321: 76-80
23. Tyrone JW, Mustoe TA. In: Plastic Surgery secrets. WeinzWeig J, Ed. Hanley & Belfus, 1999
24. Herrick SE, Sloan P, McGurk M et al. Sequential changes in the histologic pattern and extra-cellular matrix deposition during the healing of chronic veno leg ulcers. Am J Pathol 1992; 141: 1085-95
25. Harding KG. The Future of Wound Healing. In: Leaper DJ, Harding KG, eds. Wounds: Biology and Management. Oxford: Oxford University Press, 1998: 191
26. Falanga V. Chronic wounds - pathophysiologic and experimental considerations. J Invest Dermatol 1993; 100: 791-25
27. Mosely R, Stewart JE, Stephens P et al. Extra-cellular matrix metabolites as potential biomarkers of disease activity in wound fluid: lessons learned from other inflammatory diseases? Br J Dermatol 2004; 150: 401-13
28. Harding KG, Morris HL, Patel GK. Science, medicine and the future: healing chronic wounds. BMJ 2002; 324: 160-3
29. Falanga V, Eaglestein WH. The "trap" hypothesis of venous ulceration. Lancet 1993; 341: 1006-8
30. Falanga V, Eaglestein WH, Bucalo B et al. Topical use of human recombinant epidermal growth factor (h-EGF) in venous ulcers. J Dermatol Surg Oncol 1992; 18: 604-06
31. Li H, Song JH, Park JS, Han K. Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor. Int J Pharm 2003; 258: 11-19
32. Lee H, Jang IH, Ryu SH, Park TG. N-terminal site-specific mono-PEGylation of epidermal growth factor. Pharm Res 2003; 20: 818-25
33. Carpenter G. Epidermal growth factor: biology and receptor metabolism. J Cell Sci Suppl 1985; 3: 1-9
34. Chan KY, Lindquist TD, Edenfield MJ et al. Pharmacokinetic study of recombinant human epidermal growth factor in the anterior eye. Invest Ophthalmol Vis Sci 1991; 32; 3209-15
35. Fahy GM. Molecular nanotechnology. Clin Chem 1993; 39: 2011-16
36. Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov 2003; 2: 347-60
37. Matsumura Y, Maeda H. A new concept for macro-molecular therapies in cancer chemotherapy: mechanism of tumouritropic accumulation of proteins and the antitumour agent SMANCS. Cancer Res 1986; 6: 6387-92
38. Hardwicke J, Moseley R, Schmaljohann D. Bioresponsive Dextrin-EGF Conjugates Designed To Promote Tissue Regeneration In Impaired Human Wound Healing. Proceedings of the International Symposium on Polymer Therapuetics 2007, 44